Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors-Reference-Cited by-同舟云学术

Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors

Published:2018-02 Issue:1 Volume:18 Page:e7-e13
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Raghavendra Akshara,Sinha Arup K.,Valle-Goffin Janeiro,Shen Yu,Tripathy Debu,Barcenas Carlos H.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference70 articles.

1. Weight gain in breast cancer survivors: prevalence, pattern and health consequences;Vance;Obes Rev,2011

2. Long-term assessment of quality of life in the Intergroup Exemestane study: 5 years post-randomisation;Fallowfield;Br J Cancer,2012

3. Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial;Van de Velde;Lancet,2011

4. Weight gain during adjuvant endocrine treatment for early-stage breast cancer: what is the evidence?;Nyrop;Breast Cancer Res Treat,2016

5. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial;Fisher;J Natl Cancer Inst,2001

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04

2. Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment;Cancer Treatment Reviews;2024-05

3. GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report;Frontiers in Oncology;2024-04-18

4. App-Based Lifestyle Intervention (PINK! Coach) in Breast Cancer Patients—A Real-World-Data Analysis;Cancers;2024-02-29

5. Ovarian Suppression: Early Menopause, Late Effects;Current Oncology Reports;2024-01-02